📰 Bioscience Segment News
Page 3 - Bioscience Segment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bioscience Segment. Real-time updates on events, politics, business and more.
April 22, 2023
StockNews.com upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Tuesday morning. Several other equities analysts have also recently commented on GRFS. Jefferies Financial Group raised shares of Grifols from a hold rating to a buy rating in a research […]
April 16, 2023
Morgan Stanley upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from an equal weight rating to an overweight rating in a research report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the stock. Jefferies Financial Group raised shares of Grifols from a hold rating to a buy rating […]
April 16, 2023
Morgan Stanley upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from an equal weight rating to an overweight rating in a research note published on Wednesday, The Fly reports. A number of other brokerages have also issued reports on GRFS. StockNews.com lowered shares of Grifols from a buy rating to a hold rating in a […]
April 15, 2023
Morgan Stanley upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from an equal weight rating to an overweight rating in a report issued on Wednesday morning, The Fly reports. A number of other research firms have also recently commented on GRFS. StockNews.com cut Grifols from a buy rating to a hold rating in a research […]
April 14, 2023
StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note released on Monday. GRFS has been the subject of several other reports. Barclays raised shares of Grifols from an underweight rating to an equal weight rating in a report on Thursday, February 16th. Jefferies […]
April 13, 2023
StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note published on Monday morning. Other analysts also recently issued research reports about the stock. AlphaValue raised shares of Grifols to a buy rating in a research report on Monday, February 6th. Barclays raised shares […]
April 12, 2023
Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Wednesday, The Fly reports. Several other brokerages have also recently commented on GRFS. AlphaValue upgraded Grifols to a “buy” rating in a report on Monday, February 6th. Barclays upgraded shares […]
April 7, 2023
Lapides Asset Management LLC lessened its position in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 39.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 210,600 shares of the biotechnology company’s stock after selling 140,000 shares during the period. Lapides Asset Management […]
April 2, 2023
International Assets Investment Management LLC acquired a new stake in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 292,567 shares of the biotechnology company’s stock, valued at approximately $5,694,000. Grifols makes up about 1.1% of International Assets Investment Management […]
April 1, 2023
Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) have received an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective […]